Sean N. Parker Center for Allergy Research at Stanford University Named a FARE Clinical Network Center of Excellence
Stanford, Calif. — June 29, 2015— The Sean N. Parker Center for Allergy Research at Stanford University has been named a “FARE Clinical Network Center of Excellence” by Food Allergy Research & Education (FARE).
This newly established network aims to accelerate the development of drugs for patients with food allergies, as well as, improve the quality of care for this serious disorder. FARE Clinical Network members will serve as sites for clinical trials for the development of new therapeutics and will develop best practices for the care of patients with food allergies. The Network will serve as a powerful driver of collaboration to advance the field of food allergy, with member centers contributing to the development of a national food allergy patient registry and biorepositories. FARE has initially selected 22 inaugural centers of excellence, with plans to expand the number of centers to provide access to more patients.
"We’re honored to be recognized as an inaugural member of the FARE Clinical Network. A core value of the Sean N. Parker Center for Allergy Research at Stanford University is collaboration with other leading institutions and scientists to develop new therapeutic and diagnostic protocols,” said Kari Nadeau, MD, PhD, Director of the Sean N. Parker Center for Allergy Research at Stanford University.
“This new initiative will broaden the depth and breadth of clinical trials accessible to our patients and researchers," commented Sharon Chinthrajah, MD, Co-Director of the FARE Clinical Network Center of Excellence at the Sean N. Parker Center for Allergy Research at Stanford University.
Alongside Dr. Nadeau, Dr. Sharon Chinthrajah will co-direct the FARE Clinical Network Center of Excellence at the Sean N. Parker Center for Allergy Research at Stanford University.
The Sean N. Parker Center for Allergy Research at Stanford University, under the direction of Center Director Kari Nadeau, MD, PhD, currently leads and participates in many clinical trials to develop new therapies and diagnostics for allergic disorders. Our studies include a wide range of patients, representing a diverse group of ethnicities and socioeconomic backgrounds. We offer equal opportunity to all people with allergies, so long as they are eligible based on study parameters. For the latest information on trials currently being offered at Stanford and other institutions, please visit www.clinicaltrials.gov.
Food Allergy Research & Education (FARE) works on behalf of the 15 million Americans with food allergies, including all those at risk for life-threatening anaphylaxis. This potentially deadly disease affects 1 in every 13 children in the U.S. – or roughly two in every classroom. FARE’s mission is to improve the quality of life and the health of individuals with food allergies, and to provide them hope through the promise of new treatments. For more information, please visit www.foodallergy.org/research/fare-clinical-network.